Our mission at xCures is to help patients and oncologists utilize any and all resources to fight advanced cancer. As a technology platform, we offer information and decision support directly to patients and oncologists. We also connect them with third-party resources from some of the best ‘patient first’ organizations to expand treatment options and services.
Massive Bio provides access to clinical trials for every cancer patient regardless of his/her location and/or financial stability.Visit Massive Bio
Cancer Commons is a nonprofit that provides hope to advanced cancer patients by offering a highly customized and personal experience and helping them quickly identify and access their best possible treatment.Visit Cancer Commons
xCures is collaborating with CancerCompass to allow consumers who contact CancerCompass to get immediate help as well as premium access to the xCures platform and services.Visit CancerCompass
BioMed Valley Discoveries
xCures partnered with BioMed Valley Discoveries to offer expanded access to ulixertinib, a first-in-class ERK1/2 inhibitor, for patients with advanced solid tumors who are no longer responding to or have exhausted standard of care. Learn MoreVisit BioMed Valley Discoveries
xCures collaborates with POETIC, a non-profit organization that manages pediatric oncology early phase trials, to get children, adolescents, and young adults with cancer enrolled in expanded access programs of promising therapies. Learn MoreVisit POETIC
xCures is collaborating with the FibroFighters Foundation on an Observational Research Study to advance knowledge about FLHCC across the country. FLHCC is a rare cancer primarily affecting adolescents and young adults. Learn MoreVisit Fibro Fighters
Musella FoundationVisit Musella Foundation
xCures’ partnership with CureScience serves to better identify specific patients and patient populations that may benefit from a particular test or treatment.Visit CureScience
xCures is part of a historic alliance of close to a hundred life sciences and healthcare organizations that seeks to accelerate the broad adoption of patient-focused, decentralized clinical trials and research.Visit DTRA
xCures and Cancer Commons collaborated with Oncoceutics to implement an Expanded Access program for ONC201Visit Oncoceutics
Patient Record Scorecard
xCures is a supporter of the Ciitizen Patient Record Scorecard that shows how medical record providers comply with the HIPAA Right of Access based on patient requests.Visit Patient Record Scorecard
Get in touch
Want to know more about xCures? Leave your email and we’ll get back to you.